# Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

> **NCT00671008** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 400 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 30
- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT00671008
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671008, "Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00671008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*